Background illustration for clinical trials search

Paid Clinical Trials Los Angeles

Discover 3,587 paid clinical trials in Los Angeles, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

for
Relapsed and/or Refractory Multiple Myeloma
Location: Duarte CA, Stanford CA, San Francisco CA, Denver CO,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06153251

Phase 1, Recruiting

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]

for
Neoplasms, Lung
Location: Los Angeles CA, Canton OH, Toronto, Wilson NC,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07099898

Phase 3, Recruiting

Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Duarte CA, Irvine CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06260033

Phase 2, Recruiting

Characterization of Familial Myopathy and Paget Disease of Bone

for
Muscle Disorder, Bone Disorder
Location: Irvine CA
Sponsor: University of California, Irvine

Sex: All

Age: 18+

Code: NCT01166854

Recruiting

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

for
Non-Small Cell Lung Cancer
Location: Beverly Hills CA, Anaheim CA, Fountain Valley CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06357533

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705

for
Methylmalonic Acidemia
Location: Los Angeles CA, San Diego CA, Palo Alto CA, Edmonton,
Sponsor: ModernaTX, Inc.

Sex: All

Age: 1+

Code: NCT05295433

Phase 1, Phase 2, Recruiting

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

for
Multiple Myeloma
Location: Los Angeles CA, Bullhead City AZ, Fort Worth TX,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT05714839

Phase 1, Phase 2, Recruiting

Freedom-1 Study for Chronic Knee Pain

for
Osteoarthritic Knee Pain
Location: Placentia CA, Las Vegas NV, Denver CO, San Antonio TX,
Sponsor: Curonix LLC

Sex: All

Age: 18+

Code: NCT03877653

Recruiting

A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers

for
Diabetic Foot Ulcer
Location: Los Angeles CA, Sylmar CA, Fresno CA, San Francisco CA,
Sponsor: Origin Inc.

Sex: All

Age: 22 - 70+

Code: NCT03078933

Recruiting

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

for
Advanced Solid Tumors, MSI-H or dMMR Advanced Solid Tumors,
Location: Los Angeles CA, Fort Worth TX, Houston TX,
Sponsor: Eikon Therapeutics

Sex: All

Age: 18+

Code: NCT07262619

Phase 1, Phase 2, Recruiting

The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial

for
Coronary Artery Disease
Location: Long Beach CA, Dallas TX, Houston TX, Birmingham AL,
Sponsor: VA Office of Research and Development

Sex: All

Age: 18+

Code: NCT05618353

Recruiting

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

for
Psychotic Disorders, Alzheimer Disease
Location: Anaheim CA, Walnut Creek CA, Bellevue WA,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 55+

Code: NCT06540833

Phase 2, Recruiting

Early Prostate Cancer: Predicting Treatment Response

for
Prostate Cancer
Location: Los Angeles CA, West Los Angeles CA, Long Beach CA,
Sponsor: University of California, Irvine

Sex: Male

Age: 18 - 70+

Code: NCT03770351

Recruiting

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

for
Ewing Sarcoma, Colorectal Adenocarcinoma
Location: Beverly Hills CA, Los Angeles CA, Santa Monica CA,
Sponsor: Inhibrx Biosciences, Inc

Sex: All

Age: 12 - 70+

Code: NCT03715933

Phase 1, Recruiting

ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer

for
Pancreatic Cancer
Location: Los Angeles CA, San Antonio TX, Plantation FL
Sponsor: Anova Innovation Limited

Sex: All

Age: 18+

Code: NCT07444541

Phase 1, Phase 2, Recruiting

A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)

for
Neoplasms, Lung
Location: Los Angeles CA, Canton OH, Wilson NC
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07602855

Phase 1, Phase 2, Recruiting

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

for
Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma
Location: Duarte CA, Orange CA, Irvine CA, La Jolla CA,
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Sex: All

Age: 18+

Code: NCT04031677

Phase 3, Recruiting

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

for
Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer,
Location: Orange CA, Stanford CA, Sacramento CA, Aurora CO,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06128551

Phase 1, Phase 2, Recruiting

Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Los Angeles CA, San Francisco CA, Madison WI,
Sponsor: Syntrix Biosystems, Inc.

Sex: Male

Age: 18+

Code: NCT06228053

Phase 2, Recruiting

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

for
Solid Tumor, Adult
Location: Los Angeles CA
Sponsor: BioInvent International AB

Sex: All

Age: 18+

Code: NCT04219254

Phase 1, Phase 2, Recruiting

With a vast healthcare network and top-tier medical research centers, Los Angeles is a key hub for a wide range of clinical trials. Renowned institutions such as UCLA Health, Cedars-Sinai Medical Center, and the Keck School of Medicine at USC lead pioneering research across various fields, including cancer, cardiovascular health, and neuroscience.

Many Los Angeles medical centers are at the forefront of innovative studies, positioning the city as a critical location for advancing medical research and improving patient care outcomes.

Why choose Los Angeles for clinical trials?

Los Angeles offers distinct advantages for individuals participating in clinical trials. The city’s diverse population provides a wide range of participants, enhancing the accuracy and applicability of research findings across different demographics.

Known for its forward-thinking research environment, Los Angeles is home to leading institutions that drive cutting-edge studies in a variety of medical fields. By choosing to participate in a clinical trial in Los Angeles, individuals contribute to groundbreaking medical research while benefiting from the city's well-established clinical research infrastructure and access to world-class healthcare professionals.

Common conditions studied in Los Angeles

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Los Angeles